- News & Analysis
Page 859
Applied Ventures reveals Twist in investment tale
Applied Materials' corporate venturing unit has announced that it was among the investors in the synthesised gene producer's $26m round in May.
Jun 10, 2014Kineta taps partners as it targets $10m
The company, which is developing a treatment or psoriasis and arthritis, raised part of the $10m round from clinical testing companies and has now raised $46m since it was founded.
Jun 9, 2014Epinova gels TechConnect award
The Italian spin-out is one of the winners of the TechConnect Innovation Awards 2014.
Jun 9, 2014Dayima enters new period with $30m series C
The menstruation tracking app and social network has now raised $45m in total, with Bertelsmann one of the investors.
Jun 9, 2014Accelerate invests in Long Island-based companies
The seed fund has joined forces with the Long Island Emerging Technologies Fund.
Jun 9, 2014Ocugen eyes drug candidates
It will commercialise two drug candidates based on research at Colorado University.
Jun 9, 2014CareDX seeks to transplant $50m from IPO
The Intel-backed transplant surveillance technology company has filed for an initial public offering six years after it withdrew from an $86m IPO.
Jun 5, 2014About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin